糖复康对糖尿病并发“低T3综合征”的实验研究  

Experimental study on treatment of Low T3 syndrome caused by diabetes mellitus with Tangfukang

作　　者：张国豪[1] 张国治[2] 

机构地区：[1]中国中医科学院广安门医院,100053 [2]贵州省仁怀市人民医院

出　　处：《中国医学创新》2010年第5期21-23,共3页Medical Innovation of China

摘　　要：目的观察糖复康制剂对糖尿病并发“低T3综合征”大鼠模型的作用机制。方法将实验大鼠随机分为正常组、模型组、达美康组、低剂量组、高剂量组，治疗8周后，观察各组血清rT3、TSH、T3、T4、FF3、FT4水平。结果各治疗组阿3水平上升，rT3水平下降，与模型组比较差异有显著性意义（P〈0．05或P〈0．01）。结论糖复康制剂对糖尿病并发“低T3综合征”有明显调节作用。Objective To observe the mechanism of treatment of low T3 syndrome caused by diabetes mellitus in rats with Tangfukang. Methods Experimental rats were randomly divided into 5 groups： normal group, model group, Diamicron group, low dosage group, and high dosage group. The value of rT3 , TSH, T3 , T4, FT3 , FT4 were observed after 8 weeks. Results After treating, the value of FT3 increased, and the value of rT3 decreased, and they had significant differences compared with model group （ P 〈 0. 05 or P 〈 0. 01 ）. Conclusion Tangfukang play a role in treating low T3 syndrome caused by diabetes mellitus.

关 键 词：糖复康 糖尿病 低T3综合征 

分 类 号：R581[医药卫生—内分泌] R587.1[医药卫生—内科学]